ProfileGDS4718 / 235742_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 24% 35% 21% 31% 23% 35% 29% 21% 34% 26% 21% 22% 42% 35% 33% 22% 30% 36% 30% 36% 28% 27% 29% 28% 20% 31% 31% 27% 33% 41% 40% 53% 31% 28% 30% 29% 35% 30% 25% 19% 26% 28% 31% 31% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.3172124
GSM549102patient 115, normal, homogenized [OPG study]4.7932135
GSM549104patient 119, normal, homogenized [OPG study]4.1640621
GSM549108patient 138, normal, homogenized [OPG study]4.6470331
GSM549119patient 077, normal, homogenized [OPG study]4.2701923
GSM549133patient 032, cancer, homogenized [OPG study]4.6835235
GSM549139patient 042, cancer, homogenized [OPG study]4.4722529
GSM549099patient 107, normal, homogenized [OPG study]4.2032521
GSM549109patient 139, normal, homogenized [OPG study]4.7552134
GSM549110patient 046, normal, homogenized [OPG study]4.3868926
GSM549114patient 063, normal, homogenized [OPG study]4.1404521
GSM549122patient 082, normal, homogenized [OPG study]4.2154322
GSM549134patient 033, cancer, homogenized [OPG study]5.0594842
GSM549136patient 036, cancer, homogenized [OPG study]4.6922135
GSM549140patient 044, cancer, homogenized [OPG study]4.6350733
GSM549111patient 047, normal, homogenized [OPG study]4.2115222
GSM549113patient 057, normal, homogenized [OPG study]4.4772130
GSM549132patient 031, cancer, homogenized [OPG study]4.7657836
GSM549137patient 038, cancer, homogenized [OPG study]4.5095430
GSM549142patient 047, cancer, homogenized [OPG study]4.944236
GSM549100patient 110, normal, homogenized [OPG study]4.4887828
GSM549107patient 135, normal, homogenized [OPG study]4.3910427
GSM549115patient 068, normal, homogenized [OPG study]4.4442829
GSM549116patient 072, normal, homogenized [OPG study]4.4608528
GSM549120patient 078, normal, homogenized [OPG study]4.1338520
GSM549131patient 030, cancer, homogenized [OPG study]4.5096231
GSM549118patient 074, normal, homogenized [OPG study]4.5831231
GSM549129patient 027, cancer, homogenized [OPG study]4.440327
GSM549123patient 088, normal, homogenized [OPG study]4.6531333
GSM549124patient 006, cancer, homogenized [OPG study]5.0514141
GSM549126patient 015, cancer, homogenized [OPG study]4.9781140
GSM549128patient 025, cancer, homogenized [OPG study]5.6545653
GSM549103patient 117, normal, homogenized [OPG study]4.6317931
GSM549117patient 073, normal, homogenized [OPG study]4.4472628
GSM549138patient 041, cancer, homogenized [OPG study]4.5017430
GSM549141patient 045, cancer, homogenized [OPG study]4.4453929
GSM549130patient 028, cancer, homogenized [OPG study]4.7612335
GSM549101patient 111, normal, homogenized [OPG study]4.5771630
GSM549105patient 128, normal, homogenized [OPG study]4.3475425
GSM549106patient 134, normal, homogenized [OPG study]4.0501119
GSM549112patient 048, normal, homogenized [OPG study]4.3763526
GSM549125patient 011, cancer, homogenized [OPG study]4.4559128
GSM549127patient 024, cancer, homogenized [OPG study]4.567231
GSM549135patient 035, cancer, homogenized [OPG study]4.5164731